Securities Investigation- ABT Molecular Imaging
Are you concerned about your investment in ABT Molecular Imaging? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
ABT Molecular Imaging, Inc. is a medical imaging company, that designs, manufactures, markets, and services biomarker generator systems and related accessories, according to Bloomberg.
The company has filed a petition for relief under Chapter 11 in the Bankruptcy Court for the District of Delaware (Case No. 18-11398).
According to SEC filings, ABT Molecular Imaging filed a Form D to raise capital from investors in 2014 in Louisville, TN.
Investments such as these are typically sold by brokerage firms in exchange for a large up front commission. High fees can range from 7-10%, as well as additional “due diligence fees” that can range from 1-3%.
The problem with private placement investments such as ABT Molecular Imaging is that they typically involve a high degree of risk. They are also often sold as unregistered securities which lack the same regulatory oversight as more traditional investment products like stocks or bonds.
Investigating Potential Claims
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for unsuitably recommending high-risk private placements, like ABT Molecular Imaging to investors.
Despite the risks of investing in private placements, brokerage firms continue to push this type of investment because of the high commissions associated with their sale and creation.
If you have concerns regarding your investment in ABT Molecular Imaging and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visithttp://whitesecuritieslaw.com.
Tags: ABT Molecular Imaging, ABT Molecular Imaging complaints, ABT Molecular Imaging default, ABT Molecular Imaging help, ABT Molecular Imaging high commissions, ABT Molecular Imaging information, ABT Molecular Imaging investigation, ABT Molecular Imaging investment, ABT Molecular Imaging investment losses, ABT Molecular Imaging investor relations, ABT Molecular Imaging investors, ABT Molecular Imaging losses, ABT Molecular Imaging ppm, ABT Molecular Imaging private placement, ABT Molecular Imaging prospectus, ABT Molecular Imaging recovery options, ABT Molecular Imaging risk, ABT Molecular Imaging stock information, ABT Molecular Imaging update Last modified: June 14, 2018